ArticleJournal of adolescent and young adult oncology2017

Risk-Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic Leukemia in Adolescents and Young Adults.

Gregory F Guzauskas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.